Condition: Nontuberculous Mycobacterium Infection · Sponsor: Chris Goss
The purpose of this study is to assess the safety and tolerability of two 5-day infusion cycles of IV gallium in adult patients with CF who are infected with NTM. Funding Source - FDA Office of Orphan Products Development (OOPD)
This description comes directly from the study's public registry record.
Natallia Cameron · 206-884-7550 · Natallia.Cameron@seattlechildrens.org
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Recruiting |
| National Jewish Health | Denver, Colorado, United States | Recruiting |
| Johns Hopkins University | Baltimore, Maryland, United States | Recruiting |
| The Minnesota Cystic Fibrosis Center | Minneapolis, Minnesota, United States | Recruiting |
| Nationwide Children's Hospital | Columbus, Ohio, United States | Recruiting |
| University of Pittsburgh Medical Center | Pittsburgh, Pennsylvania, United States | Recruiting |
| Medical University of South Carolina | Charleston, South Carolina, United States | Recruiting |
| University of Texas Southwestern | Dallas, Texas, United States | Recruiting |
| University of Vermont Medical Center | Burlington, Vermont, United States | Recruiting |
| University of Washington Medical Center | Seattle, Washington, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04294043